Intermittent preventive treatment against malaria: an update
暂无分享,去创建一个
Daniel Chandramohan | D. Chandramohan | R. Gosling | M. Cairns | R. Chico | Roly D Gosling | Matthew E Cairns | R Matthew Chico
[1] D. Kaseje,et al. Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. I. Reasons for non-acceptance. , 1987, Annals of tropical medicine and parasitology.
[2] R. Steketee,et al. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. , 1996, The American journal of tropical medicine and hygiene.
[3] U. d’Alessandro,et al. Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa , 2009, Malaria Journal.
[4] B. Greenwood,et al. Placental malaria. II. A semi‐quantitative investigation of the pathological features , 1993, Histopathology.
[5] C. Karema,et al. Malaria has no effect on birth weight in Rwanda , 2009, Malaria Journal.
[6] K. Marsh,et al. Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae , 2001, Tropical medicine & international health : TM & IH.
[7] M. Falagas,et al. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. , 2007, International journal of antimicrobial agents.
[8] Reinhardt Mc. Maternal anaemia in Abidjan--Its influence on placenta and newborns. , 1978 .
[9] M. Fried,et al. Hypertension and Maternal–Fetal Conflict during Placental Malaria , 2006, PLoS medicine.
[10] D. Schellenberg,et al. Editorial: Intermittent preventive treatment for malaria control in infants: moving towards evidence‐based policy and public health action , 2005, Tropical medicine & international health : TM & IH.
[11] J. Ndiaye,et al. Childhood mortality and probable causes of death using verbal autopsy in Niakhar, Senegal, 1989-2000. , 2004, International journal of epidemiology.
[12] B. Cissé,et al. Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children , 2009, PloS one.
[13] W. Milhous,et al. Assessment of Azithromycin in Combination with Other Antimalarial Drugs against Plasmodium falciparum In Vitro , 2002, Antimicrobial Agents and Chemotherapy.
[14] D. Chandramohan,et al. Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed? , 2007, Malaria Journal.
[15] M. Fried,et al. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. , 1998, Journal of immunology.
[16] T. Goodwin,et al. Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. , 1999, The Journal of maternal-fetal medicine.
[17] Anne Mills,et al. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. , 2004, The American journal of tropical medicine and hygiene.
[18] Amanda Ross,et al. Modelling the Epidemiological Impact of Intermittent Preventive Treatment against Malaria in Infants , 2008, PloS one.
[19] S. Cousens,et al. Child mortality in a West African population protected with insecticide-treated curtains for a period of up to 6 years. , 2004, Bulletin of the World Health Organization.
[20] F. Binka,et al. Seasonal Intermittent Preventive Treatment for the Prevention of Anaemia and Malaria in Ghanaian Children: A Randomized, Placebo Controlled Trial , 2008, PloS one.
[21] C. Menéndez,et al. Reducing the burden of malaria in pregnancy by preventive strategies. , 2007, The Lancet. Infectious diseases.
[22] M. Tanner,et al. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. , 2009, Bulletin of the World Health Organization.
[23] P. Phillips-Howard,et al. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya. , 2003, The Journal of infectious diseases.
[24] J. Cox,et al. Altitude-dependent and -independent variations in Plasmodium falciparum prevalence in northeastern Tanzania. , 2005, The Journal of infectious diseases.
[25] A. Ghani,et al. Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? , 2008, Malaria Journal.
[26] S. Jaffar,et al. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana , 2005, BMJ : British Medical Journal.
[27] C. Whitty,et al. Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] M. Wallace,et al. Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] D. Ntirushwa. A strategic framework for malaria prevention and control during pregnancy in the African region , 2010 .
[30] S. Owusu-Agyei,et al. Duration of Protection against Malaria and Anaemia Provided by Intermittent Preventive Treatment in Infants in Navrongo, Ghana , 2008, PloS one.
[31] M. C. Bolla,et al. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment , 2009, Proceedings of the National Academy of Sciences.
[32] Usman Abdulmumini,et al. A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods , 2006, Malaria Journal.
[33] T. Theander,et al. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. , 2005, The Journal of infectious diseases.
[34] S. Sirima,et al. Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupéla District, Burkina Faso. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] K. Stȩpniewska,et al. Pharmacokinetic Determinants of the Window of Selection for Antimalarial Drug Resistance , 2008, Antimicrobial Agents and Chemotherapy.
[36] M. Tanner,et al. The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania , 2008, Malaria Journal.
[37] M. Tanner,et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants , 1997, The Lancet.
[38] Pedro Alonso,et al. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials , 2009, The Lancet.
[39] J. Whitcher,et al. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area , 1999, The British journal of ophthalmology.
[40] F. Richards,et al. Community‐directed interventions strategy enhances efficient and effective integration of health care delivery and development activities in rural disadvantaged communities of Uganda , 2005, Tropical medicine & international health : TM & IH.
[41] C. Whitty,et al. Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities , 2008, Malaria Journal.
[42] S. Adjei,et al. A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] Karen I Barnes,et al. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia , 2009, Malaria Journal.
[44] A. Kuijsten,et al. Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial , 2002, The Lancet.
[45] C. Rogier,et al. Increased susceptibility to malaria during the early postpartum period. , 2000, The New England journal of medicine.
[46] G. Jagars,et al. Treatment of acute gonococcal urethritis in men with simultaneous infection with Chlamydia trachomatis. , 1984, The British journal of venereal diseases.
[47] D. Chandramohan,et al. Duration of Protection Against Clinical Malaria Provided by Three Regimens of Intermittent Preventive Treatment in Tanzanian Infants , 2010, PloS one.
[48] M. Tanner,et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial , 2001, The Lancet.
[49] S. Adjei,et al. Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon , 2008, Malaria Journal.
[50] C. Drakeley,et al. How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? , 2007, Malaria Journal.
[51] R. Benner,et al. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. , 2005, The Journal of infectious diseases.
[52] M. Tanner,et al. The changing epidemiology of malaria in Ifakara Town, southern Tanzania , 2004, Tropical medicine & international health : TM & IH.
[53] B. Nahlen,et al. Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum‐endemic sub‐Saharan Africa , 2003, Tropical medicine & international health : TM & IH.
[54] S. Nakornchai,et al. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. , 2006, Acta tropica.
[55] J. Utzinger,et al. In a randomized controlled trial of iron fortification, anthelmintic treatment, and intermittent preventive treatment of malaria for anemia control in Ivorian children, only anthelmintic treatment shows modest benefit. , 2010, The Journal of nutrition.
[56] G. Donders. Treatment of Sexually Transmitted Bacterial Diseases in Pregnant Women , 2000, Drugs.
[57] D. McFarland,et al. Malaria chemoprophylaxis compliance in pregnant women: a cost-effectiveness analysis of alternative interventions. , 1993, Social science & medicine.
[58] S. Hay,et al. The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.
[59] David L Smith,et al. Potential Impact of Intermittent Preventive Treatment (IPT) on Spread of Drug-Resistant Malaria , 2006, PLoS medicine.
[60] R. Snow,et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya , 2008, The Lancet.
[61] M. Tanner,et al. Development of behaviour change communication strategy for a vaccination-linked malaria control tool in southern Tanzania , 2008, Malaria Journal.
[62] L. Dolovich,et al. Azithromycin-related ototoxicity in patients infected with human immunodeficiency virus. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] R. Snow,et al. Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity , 2009, Malaria Journal.
[64] R. Steketee,et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. , 2006, The Journal of infectious diseases.
[65] W. Kisoka,et al. Community directed interventions for malaria, tuberculosis and vitamin A in onchocerciasis endemic districts of Tanzania. , 2009, Tanzania journal of health research.
[66] J. Roberts,et al. Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. III. Serologic studies. , 1987, Annals of tropical medicine and parasitology.
[67] Robert E Black,et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial , 2006, The Lancet.
[68] S. Owusu-Agyei,et al. Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa? , 2007, Tropical medicine & international health : TM & IH.
[69] C. Plowe,et al. The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. , 1997, Parasitology today.
[70] Teun Bousema,et al. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials , 2008, Malaria Journal.
[71] B. Cissé,et al. A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children , 2008, PloS one.
[72] B. Brabin. An analysis of malaria in pregnancy in Africa. , 1983, Bulletin of the World Health Organization.
[73] F. Binka,et al. Mortality in a seven-and-a-half-year follow-up of a trial of insecticide-treated mosquito nets in Ghana. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[74] S. Agnandji,et al. Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial. , 2007, The Journal of infectious diseases.
[75] Thor G. Theander,et al. Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria , 2004, The Journal of experimental medicine.
[76] O. Doumbo,et al. Intermittent preventive treatment using artemisinin‐based combination therapy reduces malaria morbidity among school‐aged children in Mali , 2009, Tropical medicine & international health : TM & IH.
[77] S. Thompson,et al. Treatment of Uncomplicated Gonococcal Infection with Trime thoprim‐Sul fame thoxazole , 1982, Sexually transmitted diseases.
[78] P. Kremsner,et al. Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings , 2009, Malaria Journal.
[79] S. Oppenheimer. Iron and its relation to immunity and infectious disease. , 2001, The Journal of nutrition.
[80] D. Chandramohan,et al. Options for the Delivery of Intermittent Preventive Treatment for Malaria to Children: A Community Randomised Trial , 2009, PloS one.
[81] D. Chandramohan,et al. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.
[82] P. Kremsner,et al. Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008 , 2009, Malaria Journal.
[83] Teun Bousema,et al. Identification of hot spots of malaria transmission for targeted malaria control. , 2010, The Journal of infectious diseases.
[84] D. Chandramohan,et al. High Resistance of Plasmodium falciparum to Sulphadoxine/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581 , 2009, PloS one.
[85] C. Menéndez,et al. A Randomized Placebo-Controlled Trial of Intermittent Preventive Treatment in Pregnant Women in the Context of Insecticide Treated Nets Delivered through the Antenatal Clinic , 2008, PloS one.
[86] M. Tanner,et al. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial , 2005, The Lancet.
[87] R. Snow,et al. Malaria is an important cause of anaemia in primigravidae: evidence from a district hospital in coastal Kenya. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[88] M. Tanner,et al. Age Interactions in the Development of Naturally Acquired Immunity to Plasmodium falciparum and Its Clinical Presentation , 2007, PLoS Medicine.
[89] M. E. Wilson,et al. Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[90] P. Rosenthal,et al. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. , 2005, The American journal of tropical medicine and hygiene.
[91] B. Brabin. A comparison of maternal and foetal folacin and cobalamin activities at parturition in relation to Plasmodium falciparum infection. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[92] D. Chandramohan,et al. The safety of artemisinins during pregnancy: a pressing question , 2007, Malaria Journal.
[93] A. Ghani,et al. Loss of Population Levels of Immunity to Malaria as a Result of Exposure-Reducing Interventions: Consequences for Interpretation of Disease Trends , 2009, PloS one.
[94] Thomas Lavstsen,et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malaria , 2003, Molecular microbiology.
[95] K. Silamut,et al. Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.
[96] Ainong Zhou,et al. Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon. , 2003, The American journal of tropical medicine and hygiene.
[97] Y. Garin,et al. Placental pathologic changes in malaria. A histologic and ultrastructural study. , 1982, The American journal of pathology.
[98] K. Lindblade,et al. Sustainability of reductions in malaria transmission and infant mortality in western Kenya with use of insecticide-treated bednets: 4 to 6 years of follow-up. , 2004, JAMA.
[99] P. Alonso,et al. Malaria in pregnancy: priorities for research. , 2007, The Lancet. Infectious diseases.
[100] C. Menéndez,et al. The sick placenta-the role of malaria. , 2004, Placenta.
[101] S. Hay,et al. The decline in paediatric malaria admissions on the coast of Kenya , 2007, Malaria Journal.
[102] N. White. Open access, freely available online Policy Forum Intermittent Presumptive Treatment for Malaria A better understanding of the pharmacodynamics will guide more rational policymaking , 2022 .
[103] M. Kolczak,et al. Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya. , 2003, The American journal of tropical medicine and hygiene.
[104] Danny W. Wilson,et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum , 2002, The Lancet.
[105] Francesca Little,et al. Sulfadoxine‐pyrimethamine pharmacokinetics in malaria: Pediatric dosing implications , 2006, Clinical pharmacology and therapeutics.
[106] H. Gilles,et al. Malaria, anaemia and pregnancy. , 1969, Annals of tropical medicine and parasitology.
[107] K. Holbrook,et al. Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year , 2003, The British journal of ophthalmology.
[108] B. Cissé,et al. The IPTi Consortium: research for policy and action. , 2006, Trends in parasitology.
[109] T. Buclin,et al. Residual Antimalarials in Malaria Patients from Tanzania – Implications on Drug Efficacy Assessment and Spread of Parasite Resistance , 2009, PloS one.
[110] U. Dubach,et al. Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. , 1982, Bulletin of the World Health Organization.
[111] C. Menéndez,et al. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. , 2006, The Journal of infectious diseases.
[112] R. Snow,et al. Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[113] R. Ndyomugyenyi,et al. Intermittent preventive treatment of malaria in pregnancy (IPTp): participation of community-directed distributors of ivermectin for onchocerciasis improves IPTp access in Ugandan rural communities. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[114] U. Hellgren,et al. Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers. , 1993, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[115] D. Chandramohan,et al. Intermittent preventive treatment of malaria in infants: how does it work and where will it work? , 2009, Tropical medicine & international health : TM & IH.
[116] M. Rowland,et al. Insecticide-treated nets. , 2006, Advances in parasitology.
[117] A. Tatem,et al. The Limits and Intensity of Plasmodium falciparum Transmission : Implications for Malaria Control and Elimination Worldwide , 2007 .
[118] P. Carnevale,et al. Effect of chloroquine prophylaxis during pregnancy on maternal haematocrit. , 1998, Annals of tropical medicine and parasitology.
[119] S. Hoffman,et al. Seasonal profiles of malaria infection, anaemia, and bednet use among age groups and communities in northern Ghana , 2003, Tropical medicine & international health : TM & IH.
[120] N. White. How antimalarial drug resistance affects post-treatment prophylaxis , 2008, Malaria Journal.
[121] N. White,et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. , 1994, The Journal of infectious diseases.
[122] A. Croft,et al. Drugs for preventing malaria in travellers , 2009 .
[123] B. Sharp,et al. Multiple Origins and Regional Dispersal of Resistant dhps in African Plasmodium falciparum Malaria , 2009, PLoS medicine.
[124] B. Greenwood. Review: Intermittent preventive treatment – a new approach to the prevention of malaria in children in areas with seasonal malaria transmission , 2006, Tropical medicine & international health : TM & IH.
[125] K. Lindblade,et al. Intermittent Preventive Treatment in Infants for the Prevention of Malaria in Rural Western Kenya: A Randomized, Double-Blind Placebo-Controlled Trial , 2010, PloS one.
[126] I. Sargent,et al. Latest Advances in Understanding Preeclampsia , 2005, Science.
[127] M. Tanner,et al. The Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants in Sub-Saharan Africa , 2010, PloS one.
[128] T. Theander,et al. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial , 2003, The Lancet.
[129] C. Lengeler,et al. Insecticide-treated bed nets and curtains for preventing malaria. , 2004, The Cochrane database of systematic reviews.
[130] B. Fayomi,et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. , 2009, The Journal of infectious diseases.
[131] M Tanner,et al. Relationships between the outcome of Plasmodium falciparum infection and the intensity of transmission in Africa. , 2004, The American journal of tropical medicine and hygiene.
[132] K. Reither,et al. Intermittent Preventive Treatment in Infants as a Means of Malaria Control: a Randomized, Double-Blind, Placebo-Controlled Trial in Northern Ghana , 2007, Antimicrobial Agents and Chemotherapy.
[133] S. Meshnick,et al. Malaria infection during pregnancy: intrauterine growth retardation and preterm delivery in Malawi. , 1999, The Journal of infectious diseases.
[134] C. Rogier,et al. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. , 1994, The American journal of tropical medicine and hygiene.
[135] K. Holbrook,et al. Topical ocular antibiotics induce bacterial resistance at extraocular sites , 2005, British Journal of Ophthalmology.
[136] E. Magbity,et al. A controlled trial of lambda-cyhalothrin-impregnated bed nets and/or dapsone/pyrimethamine for malaria control in Sierra Leone. , 1998, The American journal of tropical medicine and hygiene.
[137] B. Cissé,et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial , 2006, The Lancet.
[138] A. Read,et al. Dynamics of Multiple Infection and Within‐Host Competition in Genetically Diverse Malaria Infections , 2005, The American Naturalist.
[139] T. Davis,et al. Piperaquine , 2005, Drugs.
[140] F. T. Ter Kuile,et al. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. , 2007, JAMA.
[141] M. Gomes,et al. The Impact of IPTi and IPTc Interventions on Malaria Clinical Burden – In Silico Perspectives , 2009, PloS one.
[142] K. Bojang,et al. Changes in the pattern of infant and childhood mortality in Upper River Division, The Gambia, from 1989 to 1993 , 1997, Tropical medicine & international health : TM & IH.
[143] D. Stürchler,et al. How Frequent are Notified Severe Cutaneous Adverse Reactions to Fansidar®? , 1993, Drug safety.
[144] P. Duff. Antibiotic selection in obstetric patients. , 1997, Infectious disease clinics of North America.
[145] D. Chandramohan,et al. Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy , 2008, Malaria Journal.
[146] O. Toure,et al. Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali , 2008, Malaria Journal.
[147] M. Fried,et al. Malaria vaccines: using models of immunity and functional genomics tools to accelerate the development of vaccines against Plasmodium falciparum. , 2005, Vaccine.
[148] Karen I. Barnes,et al. Association between the Pharmacokinetics and In Vivo Therapeutic Efficacy of Sulfadoxine-Pyrimethamine in Malawian Children , 2005, Antimicrobial Agents and Chemotherapy.
[149] B. Brabin,et al. An assessment of low birthweight risk in primiparae as an indicator of malaria control in pregnancy. , 1991, International journal of epidemiology.
[150] A. Dalsgaard. Editorial: Wastewater use – food safety and health aspects , 2007 .
[151] M. Tanner,et al. Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[152] K. Marsh,et al. Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[153] P. Byass,et al. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[154] Chris Newbold,et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa , 1997, The Lancet.
[155] A. Mbonye,et al. Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda , 2007, Tropical medicine & international health : TM & IH.
[156] D. Conway,et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis , 2008, The Lancet.
[157] S W Lindsay,et al. A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 6. The impact of the interventions on mortality and morbidity from malaria. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[158] J. Dushoff,et al. The entomological inoculation rate and Plasmodium falciparum infection in African children , 2005, Nature.
[159] A. Ghani,et al. Modelling the Impact of Artemisinin Combination Therapy and Long-Acting Treatments on Malaria Transmission Intensity , 2008, PLoS medicine.
[160] P. McCall,et al. Community knowledge, attitudes and practices related to tick-borne relapsing fever in dodoma rural district, central Tanzania. , 2008, Tanzania journal of health research.
[161] J. Neilson,et al. The APPLe Study: A Randomized, Community-Based, Placebo-Controlled Trial of Azithromycin for the Prevention of Preterm Birth, with Meta-Analysis , 2009, PLoS medicine.
[162] M. Fried,et al. Maternal malaria and parasite adhesion , 1998, Journal of Molecular Medicine.
[163] P. Olliaro,et al. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. , 1996, Parasitology today.
[164] M. Tanner,et al. Age-Patterns of Malaria Vary with Severity, Transmission Intensity and Seasonality in Sub-Saharan Africa: A Systematic Review and Pooled Analysis , 2010, PloS one.
[165] B. Greenwood,et al. The microepidemiology of malaria and its importance to malaria control. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[166] J. Mathews,et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[167] C. Menéndez,et al. Antimalarial drugs in pregnancy: a review. , 2006, Current drug safety.
[168] S. Meshnick,et al. A Randomized Controlled Pilot Trial of Azithromycin or Artesunate Added to Sulfadoxine-Pyrimethamine as Treatment for Malaria in Pregnant Women , 2007, PloS one.
[169] M. N. Bhattacharyya,et al. In Vitro Susceptibility of Gardnerella vaginalis to High Concentrations of Sulfonamide Compounds , 1981, Antimicrobial Agents and Chemotherapy.
[170] L. Hviid,et al. Malaria in pregnancy: pathogenesis and immunity. , 2007, The Lancet. Infectious diseases.
[171] N. White,et al. The evolution of drug-resistant malaria: the role of drug elimination half-life. , 2002, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[172] Venkatachalam Udhayakumar,et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. , 2004, The American journal of tropical medicine and hygiene.
[173] S. Brooker,et al. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial , 2008, The Lancet.
[174] J. Cox,et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. , 2005, JAMA.
[175] B. Cissé,et al. Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance , 2007, Malaria Journal.
[176] I. McGregor. Epidemiology, malaria and pregnancy. , 1984, The American journal of tropical medicine and hygiene.
[177] A. Mijch,et al. Gonococcal perianal abscess: re-emergence after cessation of co-trimoxazole , 2002, Sexually Transmitted Infections.